What is the Zelenko protocol? The Zelenko COVID-19 Protocol was developed by Dr Vladimir Zelenko. A retrospective study analyzing Dr Zelenko's patient data was accepted for publication in the International Journal of Antimicrobial Agents after a rigorous peer review process. The study finds that early intervention and treatment of high-risk patients with COVID-19 resulted in significantly fewer hospitalizations and deaths. The treatment consisting of zinc, low-dose hydroxychloroquine (HCQ), and azithromycin, is also referred to as "The Zelenko Protocol." Dr Zelenko has since updated his protocols to incorporate new evidence.
This webpage compiles content related to the early outpatient treatment protocol that has been proposed by Dr. Vladimir Zelenko for the SARS-CoV-2 virus. Dr. Zelenko originally risk-stratified patients and treated high-risk patients with hydroxychloroquine, zinc, and azithromycin.
He has since evolved his protocols to include a quercetin protocol for low-risk patients as well as guidelines for prophylaxis. Dr. Zelenko shared the details of his protocol on March and April 2020 in open letters to the medical community and also shared updated treatment and prophylaxis protocols on August 2020.
On a side note, do not confuse Zelenko protocol with the Zelenski protocol. 'The Zelenski protocol' is a popular 'twilight zone' like story by Richard Saxon.
He has also published his first research paper on his treatment protocol. Dr. Zelenko's paper establishes, with statistical significance, that his early outpatient protocol reduces hospitalizations by 84%.
Based on rapidly emerging clinical trials evidence of ivermectin, an anti-parasitic medicine, has highly potent real-world, anti-viral, and anti-inflammatory properties against COVID-19 virus, he has also included Ivermectin as part of his protocol.
Dr. Zelenko is now investigating the use of nebulized hydroxychloroquine, which could very well prove to be the final nail in the coffin for the SARS-CoV-2 pandemic. If you are interested in the inside story of how Dr. Zelenko discovered the Zelenko protocol, it is best told in his interview with Dr. Breggin [backup]. Dr. Zelenko has been banned from twitter, but you can keep up with him on Telegram.
The FLCCC (Front Line COVID-19 Critical Care Alliance) maintains a useful website with current information for medical practitioners.
Please take note that there are two Zelenko protocols:Do not get confused with the two protocols as they may appear similar. The treatment protocol is more extensive and the dosages are relatively higher as compared to the prevention protocol.
Prophylaxis is an action taken to prevent or protect against a specified disease. Greek in origin, from the word "phylax", meaning "to guard" and "watching."
Low Risk Patients - Young healthy people do not need prophylaxis against COVID-19. In young and healthy people, this infection causes mild cold-like symptoms. It is advantageous for these patients to be exposed to Covid-19, build up their antibodies and have their immune system clear the virus. This will facilitate the development of herd immunity and help prevent future Covid-19 pandemics. However, if these patients desire prophylaxis against Covid-19, then they should take the protocol noted below.
Moderate Risk Patients - Patients from this category are healthy but have high potential viral-load exposure. This group includes medical personnel, caregivers of high-risk patients, people who use public transportation, first responders and other essential personnel who are crucial to the continued functioning of society. These patients should be encouraged to take prophylaxis against Covid-19 in accordance with the protocol noted below.
High Risk Patients - Patients are considered high risk if they are over the age of 45, or if they are younger than 45 but they have comorbidities, that is, they have other health conditions that put them at risk. These patients have between a 5 to 10% mortality rate if they are infected with Covid-19. These patients should be strongly encouraged to take prophylaxis against Covid-19 in accordance with the protocol noted below.
Protocol for Low and Moderate Risk PatientsThe Zelenko protocol for low to moderate risk patients contains four nutrients that can be easily purchased over-the-counter or online i.e. quercetin, zinc, vitamin C and D3.
In an effort to make it easier for patients, Dr Zelenko has developed an oral supplement that contains all four key ingredients: vitamin C, quercetin, vitamin D3 and zinc. It’s referred to as 'Z-Stack Supplement'.
Z-Stack Vitamin cocktail provides key ingredients needed in order to help your body fight off this deadly invader. The Z-Stack Vitamins are Kosher certified, GMP certified and made in the USA.
The cost of the Z-STACK vitamin cocktail is $55 per bottle for a one month supply. Where to buy Z-Stack: Here is the link: Z Stack SupplementDr Zelenko protocol when to start? Treat patients based on clinical suspicion as soon as possible, preferably within the first 5 days of symptoms. Perform PCR testing, but do not withhold treatment pending results.
Low risk patient - Younger than 45, no co-morbidities, and clinically stable
High risk patient - Older than 45, younger than 45 with co-morbidities, or clinically unstable
Editor's Note on Vitamin D3: Preferable in oil capsules for better absorption.
Both protocols can be viewed and downloaded from his website. Note:He graduated with a B.A. degree with high honors in Chemistry from Hofstra University. After receiving an academic scholarship to attend S.U.N.Y. at Buffalo School of Medicine, he earned his M.D. degree in May 2000. Dr. Zelenko completed his family medicine residency at South Nassau Communities Hospital in Oceanside, N.Y. in May 2004. Since then, Dr. Zelenko has practiced family medicine in New York’s Hudson Valley. He has been described by his patients as like a family member to thousands of families, and is a medical adviser to the volunteer ambulance corps in Kiryas Joel, New York.
When asked about studies that seemed to discredit the efficacy of HCQ in treating the Chinese coronavirus, Zelenko explained “You don’t fire a gun without a bullet in it and then say the gun doesn’t work when you don’t kill the target. The studies that were done on HCQ did not include the use of Zinc. HCQ is what opens the cell and enables Zinc to attack the virus. One is not effective without the other, or without a suitable substitute for HCQ. The studies were designed to fail.”
Dr. Zelenko says that both prophylaxis measures and actual case treatments need to be customized to the individual. As a general rule, he says, those people who are in the higher risk groups, both by age and by other pre-existing conditions, require more aggressive actions on both the preventative and diagnostic side.
“This virus remains relatively stable inside the host for about the first five days,” Zelenko says. “After that it starts to multiply rapidly. It also starts to migrate from sinus to lungs and cardio areas where involvement becomes more severe and treatment becomes more difficult. The key is early intervention.” Zelenko again mentioned his 84% success rate in high-risk patients.
